The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease

American Journal of Hematology

Volumn 84, Issue 9, 2009, Pages 594-596

  Rossetto, Valeria ^a   Spiezia, Luca ^a   Franz, Francesca ^a   Salmaso, Laura ^b   Dalla Pozza, Laura Visonà ^b   Gavasso, Sabrina ^a   Simioni, Paolo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; VENOUS THROMBOEMBOLISM;

ANTIBODIES, ANTIPHOSPHOLIPID; CASE-CONTROL STUDIES; HUMANS; MIDDLE AGED; PROTEIN C; PROTEIN S; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 69549137883     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21466     Document Type: Article

References (30)

1. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335: 1544-1547. (Pubitemid 20189625)
2. Arvieux J, Pernod G, Regnault V, et al. Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein. Blood 1999;93:4248-4255. (Pubitemid 29279267)
3. Tripplet DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002;126: 1424-1429.
4. Oosting JD, Derksen RH, Bobbink IWG, et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism? Blood 1993;81: 2618-2625.
5. Galli M, Ruggeri L, Barbui T. Differential effects of anti-ß2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood 1998;91:1999-2004. (Pubitemid 28185500)
6. Izumi T, Pound ML, Su Z, et al. Anti-ß2-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of ß2-glycoprotein I to phospholipids. Thromb Haemost 2002;88:620-626. (Pubitemid 35174004)
7. Matsuda J, Gotoh M, Gohchi K, et al. Resistance to activated protein C activity of an anti-ß2-glycoprotein I antibody in the presence of ß2-glycoprotein I. Br J Haematol 1995;90:204-206.
8. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
9. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512-519.
10. Galli M, Willems GM, Rosing J, et al. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C. Br J Haematol 2005;129:240-247. (Pubitemid 40562445)
11. Bevers EM, Zwaal RF, Willems GM. The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin. Clin Immunol 2004;112:150-160.
12. Miesbach W, Matthias T, Scharrer I. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Ann N Y Acad Sci 2005;1050: 250-256. (Pubitemid 41129442)
13. Shibata S, Sasaki T, Harpel P, Fillit H. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes. Clin Immunol Immunopathol 1994;70:114-123. (Pubitemid 24064938)
14. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994;84:2854-2867.
15. Ehrenfort S, Radtke KP, Scharrer I. Acquired activated protein C resistance in patients with lupus anticoagulant. Thromb Haemost 1995;74:797-798.
16. Shoenfeld Y, Carp HJ, Molina V, et al. Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol 2006;56:337-344.
17. Mtiraoui N, Zammiti W, Fekih M, et al. Lupus anticoagulant and antibodies to beta2-glycoprotein I, annexin V, and cardiolipin as a cause of recurrent spontaneous abortion. Fertil Steril 2007;88:1458-1461. (Pubitemid 350030090)
18. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Deleze M, Alarcón-Segovia D. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin. J Rheumatol 1989;16:381-383. (Pubitemid 19104581)
19. Guermazi S, Mellouli F, Trabelsi S, et al. Anti-thrombomodulin antibodies and venous thrombosis. Blood Coagul Fibrinolysis 2004;15:553-558.
20. Ishikura K, Wada H, Kamikura Y, et al. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Am J Hematol 2004;76:338-342. (Pubitemid 38988617)
21. Fillit H, Lahita R. Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus erythematosus. Autoimmunity 1991;9:159-164.
22. Borrel M, Sala N, De Castellarnau C, et al. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endotelial cells. Thromb Haemost 1992;68:268-272.
23. Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990;76:101-107. (Pubitemid 20326802)
24. Nojima J, Kuratsune H, Suehisa E, et al. Association between the prevalence of antibodies to ß2-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001;47:1008-1015. (Pubitemid 32493585)
25. Nojima J, Kuratsune H, Suehisa E, et al. Acquired activated protein C resistance associated with anti-protein S antibody as a strong risk factor for DVT in non-SLE patients. Thromb Haemost 2002;88:716-722. (Pubitemid 35345325)
26. Borrel M, Tirado I, Oliver A, et al. IgM anti-protein S antibodies as a risk factor for venous thrombosis. Br J Hematol 2008;93:1115-1117. (Pubitemid 351957041)
27. Simioni P, Prandoni P, Zanon E, et al. Deep venous thrombosis and lupus anticoagulant. A case-control study. Thromb Haemost 1996;76:187-189.
28. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999;81:198-202. (Pubitemid 29078302)
29. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-1008. (Pubitemid 23053939)
30. Simioni P, Tormene D, Manfrin D, et al. Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. Br J Haematol 1998;103:1045-1050. (Pubitemid 29012641)